08045804946
Send Inquiry
Darunavir Ritonavir Tablet
7000.0 INR/Number
Product Details:
- Dosage Form Tablet
- Salt Composition Darunavir 800 mg + Ritonavir 100 mg
- Indication HIV-1 infection (as part of antiretroviral combination therapy)
- Enzyme Types Protease inhibitor (antiretroviral therapy)
- Ingredients Darunavir, Ritonavir, Excipients
- Application Used in the treatment of HIV infection
- Physical Color/Texture Film-coated tablet, white to off-white
- Click to View more
X
Darunavir Ritonavir Tablet Price And Quantity
- 1 Piece
- 7000.0 INR/Number
Darunavir Ritonavir Tablet Product Specifications
- Tablet
- Darunavir, Ritonavir, Excipients
- Store below 30C, protect from moisture and light
- Inhibits HIV protease enzyme activity
- Protease inhibitor (antiretroviral therapy)
- Darunavir 800 mg + Ritonavir 100 mg
- Used in the treatment of HIV infection
- HIV-1 infection (as part of antiretroviral combination therapy)
- 24 months Months
- Film-coated tablet, white to off-white
Darunavir Ritonavir Tablet Trade Information
- Cash in Advance (CID)
- 1000 Piece Per Week
- 2 Days
- Central America, Asia, Australia, Eastern Europe, Western Europe, Middle East, Africa, North America, South America
- Andhra Pradesh, Bihar, All India, South India, West India, North India, East India, Gujarat, Central India, Karnataka, Kerala, Lakshadweep, Mizoram, Meghalaya, Manipur, Chandigarh, Daman and Diu, Goa, Jharkhand, Odisha, Punjab, Madhya Pradesh, Maharashtra, Assam, Delhi, Haryana, Himachal Pradesh, Dadra and Nagar Haveli, Andaman and Nicobar Islands, Arunachal Pradesh, Chhattisgarh, Telangana, Jammu and Kashmir, Sikkim, Tamil Nadu, Pondicherry, Uttar Pradesh, Uttarakhand, West Bengal, Nagaland, Rajasthan, Tripura
Product Description
| Country of Origin | Made in India |
| Brand Name | NUACE |
| Manufacturer | EMCURE |
| Pack Type | Box |
| Usages | ANTI -HIV |
Nuace Tablet is a combination of antiretrovirals medicines. It is prescribedto treat HIV (human immunodeficiency virus) infection. It boosts up the immunity to fight against HIV to manage or treat AIDS (acquired immunodeficiency syndrome).
- Darunaviris an HIV-1 protease inhibitor that works by selectively binding to the active site of the HIV-1 protease enzyme. This action inhibits the enzyme's ability to cleave large viral proteins into functional components, resulting in the production of immature, non-infectious viral particles and preventing HIV replication.
- Ritonaviris primarily used as apharmacokinetic enhancer(or "booster"), rather than for its own direct antiviral effects. It inhibits the liver enzyme cytochrome P450 3A4 (CYP3A4), which is responsible for metabolizing darunavir. This inhibition limits the breakdown of darunavir, leading to higher and more sustained concentrations of darunavir in the blood, thereby increasing its effectiveness.
Powerful HIV-1 Treatment Alliance
Darunavir Ritonavir Tablet combines two potent protease inhibitors, delivering enhanced antiviral activity for adults living with HIV-1 infection. The inclusion of Ritonavir boosts the bioavailability of Darunavir, maximizing therapeutic efficacy as part of a physician-prescribed multi-drug antiretroviral regimen. Suitable for adult use only, the product is not for children under 3 years.
Convenient Bottle Packaging
Packaged securely in bottles of 30 tablets, this formulation is optimized for patient convenience and adherence. The packaging helps maintain product stability and potency, with each film-coated tablet being easy to administer orally, discreetly fitting into daily routines. Variability in box dimensions and brand-specific approvals ensure product customization across markets.
Strict Storage and Handling Guidelines
To preserve the medication's efficacy, store Darunavir Ritonavir Tablets below 30C, away from moisture and light. Following these recommendations and adhering to the 24-month shelf life ensures the product's sustained quality and reliable performance throughout its intended use.
FAQ's of Darunavir Ritonavir Tablet:
Q: How should Darunavir Ritonavir Tablets be taken?
A: These tablets should be taken orally with food, exactly as prescribed by the healthcare provider. Consistency in dosing schedule is important for optimal efficacy in HIV-1 treatment.Q: What is the main benefit of this fixed-dose combination?
A: Darunavir Ritonavir Tablets combine two protease inhibitors, with Ritonavir boosting the effectiveness and bioavailability of Darunavir. This synergy ensures a stronger inhibition of the HIV protease enzyme, helping suppress viral replication more efficiently.Q: When is this medication indicated and who should use it?
A: This product is indicated for the treatment of HIV-1 infection in adults, as part of a physician-directed antiretroviral regimen. It is not suitable for pediatric patients under 3 years of age.Q: Where should the tablets be stored for optimal stability?
A: Store the tablets in their original bottle, below 30C, and protect them from moisture and light. This ensures the medication remains potent and effective throughout its 24-month shelf life.Q: What process should a patient follow if a dose is missed?
A: If a dose is missed, patients should take it as soon as they remember unless it is near the time for the next dose. In such cases, they should skip the missed dose and resume the normal schedule-never double up doses.Q: What are the regulatory approvals and packaging formats available?
A: Regulatory approval varies by manufacturer, with certain brands being WHO prequalified or US FDA approved. The product is supplied in bottles containing 30 film-coated, odorless tablets, with box dimensions varying by manufacturer.Q: Why is this medication used as part of combination therapy?
A: Using Darunavir Ritonavir Tablets in combination with other antiretrovirals maximizes viral suppression and reduces the risk of resistance, providing comprehensive management of HIV infection per current clinical guidelines.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'HIV Medicines' category
Contact Us
- Office No. - 5, Ground Floor, D R Shopping Center, Dattapada Road, Near Hdfc Bank, Borivali East,Mumbai - 400066, Maharashtra, India
- Phone : 08045804946
- Mr Ranjeet Singh (CEO & Founder)
- Mobile : 08045804946
- medisus.pharma007@gmail.com
Send Inquiry
Send SMS
Call Me FreeMEDISUS PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
